Company intelligence / Profile preview

cereneo

Vitznau, Lucerne, Switzerlandcereneo.ch ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

cereneo provides advanced neurorehabilitation services for patients recovering from stroke, Parkinson’s disease, traumatic brain injuries, and other neurological conditions. The clinic uses the latest therapy methods and innovative technologies to maximize patient recovery through personalized treatment plans. It also engages in research to advance the field of neurorehabilitation.

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapy (focus on neurorehabilitation using advanced technology and personalized care)
Industry: Academic Hospital/University/Research

Partnerships

Collaborations with academic institutions such as University College London (UK)VU University Medical Centre Amsterdam (Netherlands)Johns Hopkins University Baltimore (USA) via its scientific advisory board

Beyond the preview

Go deeper on cereneo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on cereneo.

Explore the full profile